CEL-SCI Corp (CVM)

CEL-SCI Corp (CVM) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $31.5M; returns 1 day +1.9%, 1 week -8.4%, 1 year -81.8%.

CEL-SCI Corporation (CVM) is a clinical-stage biotechnology company focused on researching and developing immunotherapy products for treating cancer and other diseases by harnessing the body's immune system. Their lead immunotherapy, Multikine (Leukocyte Interleukin, Injection), has completed Phase III clinical trials as a potential first-line treatment for certain head and neck cancers.

Groups CVM belongs to

• Clinical Stage Biotech
• Immunotherapy
• Biotechnology
• Oncology
• Healthcare
• R&D
• Cancer Therapeutics
• Clinical Stage

CVM financial model: income statement, cash flow and balance sheet